• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测非医院获得性肺炎患者的耐甲氧西林金黄色葡萄球菌。

Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.

机构信息

Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea.

出版信息

BMC Infect Dis. 2013 Aug 9;13:370. doi: 10.1186/1471-2334-13-370.

DOI:10.1186/1471-2334-13-370
PMID:23937553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3751064/
Abstract

BACKGROUND

Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as an important cause of not only hospital acquired pneumonia, but also non-nosocomial pneumonia. However, the risk factors for non-nosocomial MRSA pneumonia are not clearly defined. Our objective was to identify risk factors at admission that were associated with non-nosocomial MRSA pneumonia.

METHODS

We evaluated 943 patients admitted to a university-affiliated hospital with culture-positive bacterial pneumonia developed outside the hospital from January 2008 to December 2011. We compared the clinical characteristics between MRSA and non-MRSA pneumonia, and identified risk factors associated with MRSA pneumonia.

RESULTS

Of 943 patients, MRSA was identified in 78 (8.2%). Higher mortality was observed in MRSA than in non-MRSA patients (33.3% vs. 21.5%; P = 0.017). In a logistic regression analysis, MRSA pneumonia was observed more frequently in patients with a previous history of MRSA infection (OR = 6.05; P < 0.001), a PSI score ≥120 (OR = 2.40; P = 0.015), intravenous antibiotic treatment within 30 days of pneumonia (OR = 2.23; P = 0.018). By contrast, non-MRSA pneumonia was observed more often in patients with a single infiltrate on chest radiography (OR = 0.55; P = 0.029).

CONCLUSIONS

Anti-MRSA antibiotics could be considered in hospitalized non-nosocomial patients with several risk factors identified herein. The presence or absence of these factors would provide useful guidance in selecting initial empirical antibiotics.

摘要

背景

耐甲氧西林金黄色葡萄球菌(MRSA)不仅是医院获得性肺炎的重要病因,也是社区获得性肺炎的重要病因。然而,社区获得性 MRSA 肺炎的危险因素尚不清楚。我们的目的是确定与社区获得性 MRSA 肺炎相关的入院时的危险因素。

方法

我们评估了 2008 年 1 月至 2011 年 12 月期间在一所大学附属医院住院的 943 例患有社区获得性细菌性肺炎的患者。我们比较了 MRSA 肺炎与非 MRSA 肺炎的临床特征,并确定了与 MRSA 肺炎相关的危险因素。

结果

943 例患者中,MRSA 感染 78 例(8.2%)。MRSA 肺炎患者的死亡率高于非 MRSA 肺炎患者(33.3% vs. 21.5%;P = 0.017)。Logistic 回归分析显示,既往有 MRSA 感染史(OR = 6.05;P < 0.001)、PSI 评分≥120(OR = 2.40;P = 0.015)、肺炎发病前 30 天内静脉应用抗生素(OR = 2.23;P = 0.018)的患者更容易发生社区获得性 MRSA 肺炎。相反,胸部 X 线片仅有单个浸润影的患者更容易发生非 MRSA 肺炎(OR = 0.55;P = 0.029)。

结论

对于存在本研究确定的多个危险因素的住院非医院获得性肺炎患者,可以考虑使用抗-MRSA 抗生素。这些因素的存在与否将为选择初始经验性抗生素提供有用的指导。

相似文献

1
Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.预测非医院获得性肺炎患者的耐甲氧西林金黄色葡萄球菌。
BMC Infect Dis. 2013 Aug 9;13:370. doi: 10.1186/1471-2334-13-370.
2
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia.用于识别因肺炎就诊于医院的患者中的耐甲氧西林金黄色葡萄球菌的风险评分。
BMC Infect Dis. 2013 Jun 6;13:268. doi: 10.1186/1471-2334-13-268.
3
Predictors of the pathogenicity of methicillin-resistant Staphylococcus aureus nosocomial pneumonia.耐甲氧西林金黄色葡萄球菌医院获得性肺炎的致病性预测因素。
Respirology. 2014 May;19(4):556-62. doi: 10.1111/resp.12288. Epub 2014 Apr 8.
4
Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.美国128家退伍军人事务医疗中心社区获得性肺炎住院患者中,经验性抗菌覆盖范围与耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌检测率的差异
Infect Control Hosp Epidemiol. 2017 Aug;38(8):937-944. doi: 10.1017/ice.2017.98. Epub 2017 Jun 21.
5
Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.金黄色葡萄球菌社区获得性肺炎:患病率、临床特征及转归
Clin Infect Dis. 2016 Aug 1;63(3):300-9. doi: 10.1093/cid/ciw300. Epub 2016 May 8.
6
Risk Factor Evaluation for Methicillin-Resistant and in Community-Acquired Pneumonia.社区获得性肺炎耐甲氧西林金黄色葡萄球菌和 感染的危险因素评估。
Ann Pharmacother. 2021 Jan;55(1):36-43. doi: 10.1177/1060028020935106. Epub 2020 Jun 16.
7
Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.经验性抗耐甲氧西林金黄色葡萄球菌(MRSA)治疗与肺炎住院患者 30 天死亡率的关系。
JAMA Intern Med. 2020 Apr 1;180(4):552-560. doi: 10.1001/jamainternmed.2019.7495.
8
Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals.社区医院耐甲氧西林金黄色葡萄球菌肺炎的流行病学
Infect Control Hosp Epidemiol. 2014 Dec;35(12):1452-7. doi: 10.1086/678594. Epub 2014 Oct 24.
9
Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital.韩国一家教学医院收治的老年患者养老院获得性肺炎的临床特征
Korean J Intern Med. 2015 Sep;30(5):638-47. doi: 10.3904/kjim.2015.30.5.638. Epub 2015 Aug 27.
10
Community-associated Panton-Valentine leukocidin-negative meticillin-resistant Staphylococcus aureus clone (ST72-MRSA-IV) causing healthcare-associated pneumonia and surgical site infection in Korea.韩国社区相关型泛-瓦氏葡萄球菌溶素阴性耐甲氧西林金黄色葡萄球菌克隆(ST72-MRSA-IV)引起的医源性肺炎和手术部位感染。
J Hosp Infect. 2012 Jul;81(3):149-55. doi: 10.1016/j.jhin.2012.04.018. Epub 2012 May 30.

引用本文的文献

1
Risk factors for drug-resistant pathogens in community-acquired pneumonia: systematic review and meta-analysis.社区获得性肺炎中耐药病原体的危险因素:系统评价与荟萃分析
Eur Respir Rev. 2025 Mar 19;34(175). doi: 10.1183/16000617.0183-2024. Print 2025 Jan.
2
Factors Associated With Multi-Drug Resistant Organisms Among Bronchiectasis Patients: A Retrospective Study of Bronchiectasis Patients in Jordan.支气管扩张症患者中与多重耐药菌相关的因素:约旦支气管扩张症患者的回顾性研究
Int J Gen Med. 2025 Jan 25;18:391-402. doi: 10.2147/IJGM.S490196. eCollection 2025.
3
Staphylococcus aureus Pneumonia in Can Tho, Vietnam: Clinical Characteristics, Antimicrobial Resistance Profile and Risk Factors of Mortality.越南芹苴市金黄色葡萄球菌肺炎:临床特征、抗菌药物耐药性及死亡风险因素
Pulm Ther. 2024 Jun;10(2):193-205. doi: 10.1007/s41030-024-00254-2. Epub 2024 Mar 6.
4
Storage stability of lysostaphin solution and its pulmonary delivery.溶葡萄球菌酶溶液的储存稳定性及其肺部递药。
Drug Deliv Transl Res. 2024 Sep;14(9):2433-2443. doi: 10.1007/s13346-024-01518-9. Epub 2024 Jan 17.
5
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.鉴定社区获得性肺炎患者中的耐药病原体。
Adv Respir Med. 2023 May 31;91(3):224-238. doi: 10.3390/arm91030018.
6
Validation of Methicillin-Resistant Staphylococcus aureus (MRSA) Risk Factors in Predicting MRSA Community-Acquired Pneumonia at an Academic Medical Center.学术医疗中心耐甲氧西林金黄色葡萄球菌(MRSA)风险因素在预测MRSA社区获得性肺炎中的验证
Hosp Pharm. 2022 Apr;57(2):223-229. doi: 10.1177/00185787211010149. Epub 2021 Apr 24.
7
In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study.耐甲氧西林金黄色葡萄球菌所致社区获得性肺炎的院内死亡率:一项配对队列研究。
BMC Pulm Med. 2021 Nov 3;21(1):345. doi: 10.1186/s12890-021-01713-1.
8
Initial antimicrobial management of sepsis.脓毒症的初始抗菌治疗。
Crit Care. 2021 Aug 26;25(1):307. doi: 10.1186/s13054-021-03736-w.
9
Staphylococcus aureus Ventilator-Associated Pneumonia: A Study of Bacterio-Epidemiological Profile and Virulence Factors.金黄色葡萄球菌呼吸机相关性肺炎:细菌流行病学特征及毒力因子研究
Curr Microbiol. 2021 Jul;78(7):2556-2562. doi: 10.1007/s00284-021-02512-x. Epub 2021 May 10.
10
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.成人社区获得性肺炎诊断和治疗。美国胸科学会和美国传染病学会的官方临床实践指南。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST.

本文引用的文献

1
Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia.目前的医疗保健相关性肺炎标准对潜在耐药病原体的预测能力较差。
Respir Med. 2012 Sep;106(9):1311-9. doi: 10.1016/j.rmed.2012.04.003. Epub 2012 May 4.
2
Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia.社区获得性肺炎中耐甲氧西林金黄色葡萄球菌的发病情况。
Clin Infect Dis. 2012 Apr;54(8):1126-33. doi: 10.1093/cid/cis022.
3
Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA).管理耐甲氧西林金黄色葡萄球菌(MRSA)引起的严重社区获得性肺炎。
Curr Infect Dis Rep. 2012 Jun;14(3):330-8. doi: 10.1007/s11908-012-0254-8.
4
Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.医护相关性肺炎的流行病学、抗生素治疗和临床结局:一项英国队列研究。
Clin Infect Dis. 2011 Jul 15;53(2):107-13. doi: 10.1093/cid/cir274.
5
Healthcare-associated pneumonia: the state of evidence to date.医疗机构相关性肺炎:现有证据的状况。
Curr Opin Pulm Med. 2011 May;17(3):142-7. doi: 10.1097/MCP.0b013e328343eb33.
6
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.美国传染病学会发布的耐甲氧西林金黄色葡萄球菌感染成人和儿童治疗临床实践指南。
Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4.
7
Rethinking the concepts of community-acquired and health-care-associated pneumonia.重新思考社区获得性肺炎和医院获得性肺炎的概念。
Lancet Infect Dis. 2010 Apr;10(4):279-87. doi: 10.1016/S1473-3099(10)70032-3.
8
Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia.社区获得性耐甲氧西林金黄色葡萄球菌肺炎的扩展临床表现。
Chest. 2010 Jul;138(1):130-6. doi: 10.1378/chest.09-1562. Epub 2010 Feb 19.
9
Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?非医院获得性肺炎和呼吸衰竭中的耐药病原体:是否需要重新定义医疗保健相关性肺炎?
Chest. 2010 Jun;137(6):1283-8. doi: 10.1378/chest.09-2434. Epub 2010 Feb 12.
10
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia.耐甲氧西林金黄色葡萄球菌作为肺部感染(包括气道感染、社区获得性肺炎和医院获得性肺炎)的病因。
Eur Respir J. 2009 Dec;34(6):1470-6. doi: 10.1183/09031936.00122309.